Compare · ACCD vs CHAQ
ACCD vs CHAQ
Side-by-side comparison of Accolade Inc. (ACCD) and Chardan Healthcare Acquisition 2 Corp. (CHAQ): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while CHAQ operates in Finance - the two are in different parts of the market.
- ACCD is the larger of the two at $1.18B, about 13.0x CHAQ ($90.6M).
- ACCD has more recent analyst coverage (25 ratings vs 0 for CHAQ).
- Company
- Accolade Inc.
- Chardan Healthcare Acquisition 2 Corp.
- Price
- $7.03+0.00%
- $8.50-8.90%
- Market cap
- $1.18B
- $90.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- AMEX
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Chardan Healthcare Acquisition 2 Corp.
Chardan Healthcare Acquisition 2 Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, stock purchase, recapitalization, reorganization, or other similar business combination. The company was incorporated in 2018 and is based in New York, New York.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest CHAQ
- SEC Form S-1 filed by Chardan Healthcare Acquisition 2 Corp.
- Chardan Healthcare Acquisition 2 Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form SC 13D filed by Chardan Healthcare Acquisition 2 Corp.
- Chardan Healthcare Acquisition 2 Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Unregistered Sales of Equity Securities, Changes in Registrant’s Certifying Accountant, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Financial Statements and Exhibits
- SEC Form 4 filed by Needham Thomas E. Jr.
- SEC Form 3 filed by new insider Needham Thomas E. Jr.
- SEC Form 4 filed by Lau Joan
- SEC Form 4 filed by Killeen Matthew
- SEC Form 4 filed by Covino Gregory F
- SEC Form 4 filed by Benz Edward J. Jr